Emcure Pharmaceuticals Financials
| EMCURE Stock | 1,421 33.45 2.41% |
Operating Margin 0.1337 | PE Ratio 54.2911 | Profit Margin 0.074 |
Emcure |
Understanding current and past Emcure Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Emcure Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in Emcure Pharmaceuticals' assets may result in an increase in income on the income statement.
Please note, the presentation of Emcure Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Emcure Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Emcure Pharmaceuticals' management manipulating its earnings.
Emcure Pharmaceuticals Stock Summary
Emcure Pharmaceuticals competes with Akums Drugs, Innova Captab, Kingfa Science, and Rico Auto. Emcure Pharmaceuticals is entity of India. It is traded as Stock on NSE exchange.Specialization | Healthcare, Drug Manufacturers - Specialty & Generic |
| Instrument | India Stock View All |
| Exchange | National Stock Exchange of India |
| ISIN | INE168P01015 |
| Business Address | Plot No P-1 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.emcure.com |
| Phone | 91 20 3507 0033 |
You should never invest in Emcure Pharmaceuticals without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Emcure Stock, because this is throwing your money away. Analyzing the key information contained in Emcure Pharmaceuticals' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Emcure Pharmaceuticals Key Financial Ratios
Emcure Pharmaceuticals' financial ratios allow both analysts and investors to convert raw data from Emcure Pharmaceuticals' financial statements into concise, actionable information that can be used to evaluate the performance of Emcure Pharmaceuticals over time and compare it to other companies across industries.Emcure Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Emcure Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Emcure Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Emcure Pharmaceuticals competition to find correlations between indicators driving Emcure Pharmaceuticals's intrinsic value. More Info.Emcure Pharmaceuticals is rated below average in profit margin category among its peers. It also is rated below average in operating margin category among its peers reporting about 1.81 of Operating Margin per Profit Margin. Comparative valuation analysis is a catch-all model that can be used if you cannot value Emcure Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Emcure Pharmaceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Emcure Pharmaceuticals Systematic Risk
Emcure Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Emcure Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Emcure Pharmaceuticals correlated with the market. If Beta is less than 0 Emcure Pharmaceuticals generally moves in the opposite direction as compared to the market. If Emcure Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Emcure Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Emcure Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Emcure Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
Emcure Pharmaceuticals December 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Emcure Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Emcure Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Emcure Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Emcure Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Emcure Pharmaceuticals's daily price indicators and compare them against related drivers.
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 11.6 | |||
| Value At Risk | (3.87) | |||
| Potential Upside | 3.6 |
Complementary Tools for Emcure Stock analysis
When running Emcure Pharmaceuticals' price analysis, check to measure Emcure Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emcure Pharmaceuticals is operating at the current time. Most of Emcure Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Emcure Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emcure Pharmaceuticals' price. Additionally, you may evaluate how the addition of Emcure Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |